Ecallantide is a novel treatment for attacks of hereditary angioedema due to C1 inhibitor deficiency

Overview of attention for article published in Clinical, Cosmetic and Investigational Dermatology, May 2011

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)

Mentioned by

twitter: 2 X users

patent: 2 patents

Citations

dimensions_citation: 28 Dimensions

Readers on

mendeley: 29 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Inhibitors of plasma kallikrein and uses thereof

Grant US-11905285-B2

United States of America

Inhibitors of Plasma Kallikrein and uses thereof

Grant US-11168083-B2

United States of America